Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 Infection

Zeuzem S, Foster GR, Wang S, et al. Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 Infection. N Engl J Med. 2018;378(4):354-369.

Publication Type:

Journal Article

Source:

N Engl J Med, Volume 378, Issue 4, p.354-369 (2018)
Top